Cargando…

Impact of Anti-Tumor Necrosis Factor and Thiopurine Medications on the Development of COVID-19 in Patients With Inflammatory Bowel Disease: A Nationwide Veterans Administration Cohort Study

Detalles Bibliográficos
Autores principales:	Khan, Nabeel, Patel, Dhruvan, Xie, Dawei, Lewis, James, Trivedi, Chinmay, Yang, Yu-Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the AGA Institute 2020
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258834/ https://www.ncbi.nlm.nih.gov/pubmed/32479823 http://dx.doi.org/10.1053/j.gastro.2020.05.065

Ejemplares similares

Adherence of Infusible Biologics During the Time of COVID-19 Among Patients With Inflammatory Bowel Disease: A Nationwide Veterans Affairs Cohort Study
por: Khan, Nabeel, et al.
Publicado: (2020)

Albumin as a prognostic marker for ulcerative colitis
por: Khan, Nabeel, et al.
Publicado: (2017)

Thiopurine Methyltransferase Activity and Thiopurine Metabolites in Inflammatory Bowel Disease
por: El-Matary, Wael
Publicado: (2020)

Impact of thiopurine dose in anti-tumor necrosis factor combination therapy on outcomes in inflammatory bowel disease
por: Nawaz, Ahmad, et al.
Publicado: (2023)

Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?
por: Gargallo-Puyuelo, Carla J., et al.
Publicado: (2021)

Adverse Events Related to SARS-CoV-2 Vaccine in a Nationwide Cohort of Patients With Inflammatory Bowel Disease
por: Mahmud, Nadim, et al.
Publicado: (2022)

Thiopurine methyltransferase genotype and thiopurine S-methyltransferase activity in Greek children with inflammatory bowel disease
por: Gazouli, Μaria, et al.
Publicado: (2012)

Use of thiopurines in inflammatory bowel disease: an update
por: Singh, Arshdeep, et al.
Publicado: (2022)

Association of Anti–Tumor Necrosis Factor Therapy With Mortality Among Veterans With Inflammatory Bowel Disease
por: Cohen-Mekelburg, Shirley, et al.
Publicado: (2021)

Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel Disease
por: Zakerska-Banaszak, Oliwia, et al.
Publicado: (2022)

Risk of Venous Thromboembolism Among Patients With Inflammatory Bowel Disease Who Contract Severe Acute Respiratory Syndrome Coronavirus 2
por: Mahmud, Nadim, et al.
Publicado: (2021)

Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan
por: Komoto, Shunsuke, et al.
Publicado: (2016)

Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System
por: Khan, Nabeel, et al.
Publicado: (2021)

Thiopurine metabolite level and toxicity in Indians with inflammatory bowel disease
por: Parkar, Suruchi P, et al.
Publicado: (2017)

Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel Disease
por: Cornish, Jack S., et al.
Publicado: (2020)

Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases
por: Tominaga, Keiichi, et al.
Publicado: (2021)

Safety and Efficacy of Split-Dose Thiopurine vs Low-Dose Thiopurine-Allopurinol Cotherapy in Pediatric Inflammatory Bowel Disease
por: Cococcioni, Lucia, et al.
Publicado: (2022)

Monitoring Thiopurine Metabolites in Korean Pediatric Patients with Inflammatory Bowel Disease
por: Kim, Mi Jin, et al.
Publicado: (2014)

Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective
por: Axelrad, Jordan E, et al.
Publicado: (2016)

How I treat my inflammatory bowel disease-patients with thiopurines?
por: Meijer, Berrie, et al.
Publicado: (2016)

Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?
por: Luber, Raphael P., et al.
Publicado: (2019)

Association between Thiopurine S-methyltransferase Polymorphisms and Thiopurine-Induced Adverse Drug Reactions in Patients with Inflammatory Bowel Disease: A Meta-Analysis
por: Liu, Yue-Ping, et al.
Publicado: (2015)

Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease
por: Simsek, Melek, et al.
Publicado: (2017)

Nodular regenerative hyperplasia in inflammatory bowel disease patients with allopurinol–thiopurine cotherapy
por: Simsek, Melek, et al.
Publicado: (2018)

Xanthine oxidase activity in thiopurine curative Chinese inflammatory bowel disease patients
por: Ding, Liang, et al.
Publicado: (2021)

Thiopurines are an independent risk factor for active tuberculosis in inflammatory bowel disease patients
por: Fortes, Flora Maria Lorenzo, et al.
Publicado: (2023)

Preventative care for patients with inflammatory bowel disease in the Veterans Health Administration
por: Pandey, Nivedita, et al.
Publicado: (2016)

COVID-19 Vaccine Effectiveness Against the Omicron Variant in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease
por: Khan, Nabeel, et al.
Publicado: (2023)

The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients
por: Bastida, Guillermo, et al.
Publicado: (2010)

Rac Attack: Modulation of the Small GTPase Rac in Inflammatory Bowel Disease and Thiopurine Therapy
por: Seinen, Margien L., et al.
Publicado: (2016)

The impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference?
por: Chhaya, Vivek, et al.
Publicado: (2013)

Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2019)

Thiopurine use associated with reduced B and natural killer cells in inflammatory bowel disease
por: Lord, James D, et al.
Publicado: (2017)

Thiopurine S-methyltransferase genetic polymorphisms in adult patients with inflammatory bowel diseases in the Latvian population
por: Zalizko, Polina, et al.
Publicado: (2020)

NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease
por: Matsuoka, Katsuyoshi
Publicado: (2020)

Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy
por: Jansen, Fenna M., et al.
Publicado: (2023)

Coronavirus disease 2019 in veterans receiving care at veterans health administration facilities
por: Luo, Jessica, et al.
Publicado: (2021)

Lack of Increased Risk of Lymphoma by Thiopurines or Biologics in Japanese Patients with Inflammatory Bowel Disease: A Large-Scale Administrative Database Analysis
por: Kobayashi, Taku, et al.
Publicado: (2020)

Rural Veterans’ Experiences With Outpatient Care in the Veterans Health Administration Versus Community Care
por: Davila, Heather, et al.
Publicado: (2021)

Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients
por: Khan, Nabeel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qri8duatpbjp2bvpa51v7d9oqh